PDRN Eye Cream for the U.S. Market: Sourcing, Formulation, and Claim Considerations
PDRN (Polydeoxyribonucleotide) has transitioned from a niche injectable ingredient to a rising star in topical skincare, and the eye cream category is…
See the factory by live video walkthrough
Book an on-site factory visit in Guangzhou
Sourcing notes for private label eye care: texture targets, claim framing, packaging options, and stability/micro planning. Built for brand owners and product teams who need RFQ-ready specs.
Buyer-critical decisions first: MOQ, lead time, compliance, packaging fit.
PDRN (Polydeoxyribonucleotide) has transitioned from a niche injectable ingredient to a rising star in topical skincare, and the eye cream category is…
For U.S. beauty brands, the lash serum category is undergoing a sharp pivot. Traditional formulas that rely on prostaglandin analogs—such as isopropyl…
Navigating hydrogel eye patch manufacturing can feel like solving a puzzle with four interconnected pieces: the gel material, how serum is loaded,…
Skim, shortlist, then reuse checklists in your supplier RFQs.
For cosmetic brands, the under-eye area represents both a major consumer concern and a regulatory tightrope. Formulating a product that credibly addresses “dark circles” requires understanding that the condition is…
Eye creams and serums that target puffiness and under-eye bags are among the most sought‑after products in the skincare aisle. Yet brands often stumble when crafting marketing claims—the line between…
Formulating an anti-wrinkle eye cream is only half the battle—what you say about it on your label and website determines whether the FDA views it as a cosmetic or an…
When developing an eye cream, the delicate skin around the eyes creates both a high-value opportunity and a high-stakes challenge for brands. Consumers are skeptical—they have been burned by promises…
Consumer perception studies are a critical tool for eye care brands looking to transform real user experiences into believable, defensible marketing claims. Whether you’re developing a new lubricating eye drop,…
When a new eye-area cosmetic line moves from concept to production—eyeshadow, mascara, brow pencils, or eyeliner—the single largest regulatory risk often hides in the color palette. The U.S. FDA tightly…
MoCRA (the Modernization of Cosmetics Regulation Act) has reshaped the safety substantiation landscape for all cosmetic products sold in the United States. For eye care formulations—where the safety margin is…
Every U.S. brand, importer, or manufacturer of eye care products—whether OTC drops, contact lens solutions, or cosmetic eye creams—needs a clear, defensible process for documenting adverse events. Under FDA regulations,…
In the ophthalmology and eye care sector, a product recall is not just a logistical headache—it is a patient safety emergency. Whether you are sourcing artificial tears, contact lens solutions,…
Eye-area products like creams, serums, and under-eye patches sit at the intersection of luxury skincare and heightened safety demands. The eye’s mucosal proximity and thin, permeable skin make these formulas…